ALCMI-012 A Prospective Biospecimen Collection Study from Patients with EGFR mutant Tumors study.
We are conducting a research study to develop up to 10 Patient Derived Xenograft models (a way to study cancer) for EGFR mutant driven cancers to be used to study tumor growth, response to anti-cancer therapies.
The first step to participating in this study is to speak with our study team. We will ask you a few basic demographic questions (such as your age, gender, race and ethnicity) and about your planned EGFR mutant cancer biopsy or surgery. The call will last approximately 30 minutes.
Send us a message, call the EGFR Study Hotline 888-403-EGFR (3437), or email clinicalops@alcmi.net and our study staff will coordinate a call with you!
Thank you everyone!
My precious Husband
